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ABSTRACT
The alternative sigma factor RpoN is an essential
colonization factor of Vibrio cholerae and controls
important cellular functions including motility and
type VI secretion (T6SS). The RpoN regulon has
yet to be clearly defined in T6SS-active V. cholerae
isolates, which use T6SS to target both bacterial
competitors and eukaryotic cells. We hypothesize
that T6SS-dependent secreted effectors are
co-regulated by RpoN. To systemically identify
RpoN-controlled genes, we used chromatin
immunoprecipitation coupled with sequencing
(ChIP-Seq) and transcriptome analysis (RNA-Seq)
to determine RpoN-binding sites and RpoN-
controlled gene expression. There were 68 RpoN-
binding sites and 82 operons positively controlled
by RpoN, among which 37 operons had ChIP-
identified binding sites. A consensus RpoN-binding
motif was identified with a highly conserved thymine
(14) and an AT-rich region in the middle between
the hallmark RpoN-recognized motif GG(24)/
GC(12). There were seven new RpoN-dependent
promoters in the flagellar regions. We identified a
small RNA, flaX, downstream of the major flagellin
gene flaA. Mutation of flaX substantially reduced
motility. In contrast to previous results, we report
that RpoN positively regulates the expression of
hcp operons and vgrG3 that encode T6SS secreted
proteins but has no effect on the expression of the
main T6SS cluster encoding sheath and other struc-
tural components.
INTRODUCTION
Cholera is a serious threat to public health in the develop-
ing countries. The cholera outbreak in Haiti has resulted
in >6000 deaths and about a half-million conﬁrmed
cases (1). As the causative pathogen for cholera, Vibrio
cholerae has many virulence factors including cholera
toxin, the critical colonization factor TCP pili, and viru-
lence regulators ToxR and ToxT [reviewed in (2)]. A
newly identiﬁed protein secretion system, Type VI secre-
tion system (T6SS), has also been implicated in the viru-
lence of V. cholerae by causing cytotoxicity in macrophage
and inducing intestinal inﬂammation (3–5).
T6SS is a conserved protein delivery system present in
>100 Gram-negative bacterial species including many
important pathogens, V. cholerae (5), Pseudomonas aeru-
ginosa (6), Burkholderia thailandensis (7), Serratia
marcescens (8) and avian pathogenic Escherichia coli (9).
In V. cholerae, T6SS genes are organized in one large locus
consisting of 17 genes encoding mostly basal components
and two hcp-vgrG operons encoding secreted proteins (5)
(Supplementary Figure S1). Structural analysis shows that
T6SS components are highly similar to phage tail proteins
(10,11). For example, the T6SS-secreted Hcp and VgrG
proteins are homologous to the tail tube protein
and spike-like protein of T4 phage, respectively (11).
Expression of T6SS genes is regulated by quorum
sensing, TsrA and RpoN (5,12,13).
RpoN is an alternative sigma factor that binds to the
core RNA polymerase and directs gene expression from
RpoN-recognized promoters (14). RpoN positively regu-
lates the expression of 70 genes in E. coli K-12,
including genes for motility and nitrogen assimilation
(15). However, the RpoN regulon has not been clearly
deﬁned in V. cholerae. RpoN-mediated transcription
requires an enhancer that activates transcription by
binding to upstream regions (16). The T6SS locus
encodes an RpoN-enhancer VasH that is required for
Hcp secretion and T6SS function (17). RpoN is essential
for colonization in V. cholerae O1 classical strain O395,
and it controls motility and expression of glutamine
synthetase GlnA (18). However, the colonization defect
of the rpoN mutant is not because of loss of motility or
GlnA expression, suggesting the involvement of other
RpoN-controlled traits (18). Microarray proﬁling studies
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motility (20) show the expression of a large number of
genes is altered in rpoN mutants of V. cholerae O1 El
Tor strain and serotype O1 classical strain O395, respect-
ively. Interestingly, T6SS genes are up-regulated in the
rpoN mutants of these strains (19,20). This difference in
RpoN control of T6SS is likely because of strain variation,
as T6SS is not active in the seventh pandemic V. cholerae
O1 El Tor strain and O395 strain under laboratory con-
ditions (5). In addition, heterologous expression of
T6SS-promoter reporter fusions was shown to be RpoN-
dependent (21), suggesting that the T6SS cluster and hcp
operons are co-regulated by RpoN.
T6SS targets both eukaryotic hosts and prokaryotic
competitors, although the mechanism is not fully under-
stood. Pseudomonas aeruginosa T6SS secretes effector
proteins that are toxic to E. coli by degrading peptidogly-
can (22,23). T6SS of V. cholerae is also required for killing
E. coli (24), but the effectors have not been clearly deﬁned.
The actin-crosslinking domain of VgrG1 is translocated
into macrophage cells resulting in cytotoxicity (4,25),
and a newly identiﬁed secreted factor VasX is important
for T6SS-mediated virulence in the model amoeba
Dictyostelium discoideum (26).
In this study, our primary interest is to fully understand
the regulatory role of RpoN in T6SS secretion and other
cellular functions in V. cholerae. Chromatin-immuno-
precipitation coupled with next-generation sequencing,
ChIP-Seq, provides a powerful tool to identify protein–
DNA interactions. ChIP-Seq has been mostly used in
eukaryotic systems and there are few reports in bacteria.
Our lab previously demonstrated the effectiveness of
ChIP-Seq in bacterial studies and identiﬁed the Fur
regulon in V. cholerae (27). Here we used the same
approach combined with RNA-Seq to characterize the
RpoN regulon in a T6SS-active, serotype O37 clinical
isolate V52. There were 37 operons that show RpoN-
dependent expression and RpoN-binding sites, indicative
of direct control by RpoN. We uncovered new RpoN-
controlled promoters in the ﬂagellar gene clusters, and
a small RNA that is important for motility. In addition,
RpoN was found to selectively control the expression
of T6SS secreted proteins but not the structural
components.
MATERIALS AND METHODS
Bacterial strains and growth conditions
Strains and plasmids are listed in Table 1. A serotype O37
clinical isolate of V. cholerae strain V52 was used in this
study. Escherichia coli DH5a and SM10  pir were used
for cloning and conjugation, respectively. Antibiotics
were used at the following concentrations: ampicillin
(100mg/ml), streptomycin (100mg/ml), kanamycin
(50mg/ml) and chloramphenicol (2.5mg/ml for V. cholerae
and 25mg/ml for E. coli). Arabinose (0.1%) was used for
induction, unless otherwise speciﬁed. Motility was tested on
Luria Bertani (LB) medium with 0.3% agar.
All strains were routinely grown at 37C in LB medium
containing 5g/l sodium chloride. For ChIP- and RNA-
Seq analyses, cultures were grown in LB medium to expo-
nential phase (OD600=0.5) and induced with 0.1%
arabinose for 30minutes at 37C.
DNA manipulation
In-frame gene deletion in V. cholerae was performed as
described (28,29). Brieﬂy, the ﬂanking region of the
respective gene was ampliﬁed by crossover PCR, cloned
into the pWM91 suicide vector, and transferred into
recipient strains through conjugation. Independent trans-
conjugants were puriﬁed and incubated on 5% sucrose to
select for sucrose-resistant segregants. Deletion was con-
ﬁrmed by sequencing. For gene induction, the respective
gene was PCR-ampliﬁed, digested with KpnI and SalI,
and cloned into the pBAD18 plasmid (31) carrying a
C-terminal 3xV5 epitope tag (32). The small RNA ﬂaX
was cloned into a plasmid pNM12, a pBAD24-derivative
vector that lacks ribosomal binding sites upstream of the
cloning site and is commonly used for expressing sRNAs
(30). All constructs were veriﬁed by sequencing. Primers
used in this study are listed in Supplementary Table S1.
Western blot
Proteins were resolved in a precast 10% SDS PAGE gel
(Life Technologies) and transferred to a PVDF membrane
(Millipore) by electrophoresis. The membrane was then
blocked in 5% non-fat milk for 1 hour at room tempera-
ture, and incubated with respective monoclonal antibodies
at 4C overnight. The monoclonal antibodies to V5-tag,
Table 1. Strains and plasmids used in this study
Strain and plasmid Genotype or phenotype Reference
V. cholerae
V52 Serotype 37 clinical isolate from Sudan Pukatzki et al., 2006 (5)
V52 rpoN Knock-out rpoN mutant of V52 This study
T6SS mutants Nonpolar deletion mutants of V52 Zheng et al., 2010 (12)
SM10 thi thr leu tonA lac Y supE recA::RP4-2-Tc::Mu Miller and Mekalanos, 1988 (28)
Plasmid
pWM91 Suicidal conjugation vector Metcalf et al., 1996 (29)
pBAD18V5 Expression vector with 3xV5 tag Davies et al., 2011 (27)
pRpoN The rpoN gene cloned into pBAD18V5 This study
pNM12 sRNA expression vector derivative of pBAD24 Majdalani et al., 1998 (30)
pﬂaX ﬂaX inserted between NheI and KpnI sites on pNM12 This study
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NeoClone and laboratory stock, respectively. The
membrane was then washed three times in TBST buffer
(50mM Tris, 150mM NaCl, 0.05% Tween-20, pH 7.6)
and incubated with a HRP-conjugated secondary
antibody (Pierce) for 1 hour at room temperature.
Signals were detected using the ECL solution and ECL
ﬁlms (Amersham). Western blotting was performed at
least twice for each experiment.
Protein secretion assay
Cultures were grown in LB medium to exponential
phase (OD600=0.5). Expression was induced by 0.1%
L-arabinose for 1 hour. One millilitre culture was
centrifuged twice at 20 000g for 2minutes, and the
supernatant was then ﬁltered through a 0.2-mm ﬁlter. A
mixture of 900ml of supernatant and 100ml of 100% TCA
solution was placed on ice for 2 hours and centrifuged at
15 000g for 20minutes at 4C. The supernatant was
discarded and the pellet was washed twice with 1ml of
100% acetone by centrifugation at 20 000g for 5mi-
nutes. The resultant pellet was mixed with 30mlo f
SDS-loading dye and proteins analyzed by western blot
analysis.
Chromatin immunoprecipitation paired with next-
generation sequencing ChIP-Seq
ChIP assay was performed as described previously (27).
Brieﬂy, 50ml culture was mixed with formaldehyde (1%
ﬁnal concentration) for cross-linking at room temperature
for 20minutes, and the reaction was quenched by glycine
(0.5M). Cells were collected by centrifugation, washed
twice with TBS buffer, and resuspended in 1ml lysis buffer
(10mM Tris, 100mM NaCl, 1mM EDTA, 0.5mM
EGTA, 0.1% deoxycholate, 0.5% N-lauroylsarcosine,
pH 8.0) with protease inhibitor cocktail (Sigma). Cells
were then lysed with 1mg/ml lysozyme at 37C for 30mi-
nutes and sonicated for 10minutes using a cup horn
sonicator at 60% power setting (Misonix). Cell debris
was removed by centrifugation at 16 000g for 15mi-
nutes at 4C, and the supernatant containing DNA frag-
ments with an average size of 200bp was incubated with
pretreated Dynal-Protein G beads coated with anti-V5
monoclonal antibody (Sigma). A control sample (100ml)
was taken before Dynal-bead treatment. ChIP reaction
was carried out at 4C overnight on a rotary shaker,
and samples were washed ﬁve times with RIPA buffer
(50mM HEPES buffer, 500mM LiCl, 1mM EDTA, 1%
Nonidet P-40, 0.7% deoxycholate, pH 7.5) and once with
TBS buffer. ChIP DNA was eluted in 100ml elution buffer
(50mM TE buffer, 1% EDTA, pH 7.5) at 65C for 30mi-
nutes and de-cross-linked by incubation at 65C over-
night. Samples were then treated with RNase A and
proteinase K, and puriEed with a ChIP DNA clean kit
(Zymo). Experiments were performed in triplicate.
RNA extraction
RNA was extracted from three independent replicates of
exponential phase cultures using acidic phenol (pH 4.3,
Sigma) and puriﬁed with a Direct-zol RNA kit (Zymo).
The quality of RNA was examined with Bioanalyzer
(Agilent). Ten micrograms of total RNA was treated
with an Ambion rRNA kit to remove ribosomal RNA,
and the efﬁciency was conﬁrmed by Bioanalyzer analysis.
Library construction and Illumina HiSeq sequencing
Libraries for ChIP-Seq and RNA-Seq were prepared using
NEBNext ChIP-Seq Sample Prep Master Mix Set 1
(NEB) and NEBNext mRNA Sample Prep Master Mix
kit (NEB), respectively. Brieﬂy, ChIP DNA was
end-repaired ligated to Illumina adaptors, and selected
for a fragment size of around 200bp by gel extraction.
RNA samples were treated similarly, except for two add-
itional steps of fragmentation and cDNA synthesis before
end-repair. Multiplex Illumina primers were used to
PCR-amplify gel-extracted products, and products were
puriﬁed with a DNA clean-up kit (Zymo).
Sequencing was performed using an Illumina
HiSeq2000 platform in the Biopolymer core facility at
Harvard Medical School. ChIP-Seq and RNA-Seq reads
were mapped to V. cholerae N16961 genome using the
software CLC Genomics Workbench as previously
described (27). ChIP-Seq and RNA-Seq data generated
average genome coverage of 4-fold and 40-fold, respect-
ively. Three independent ChIP samples were compared
with the reference, and enriched peaks were detected by
scanning the genome with a 120-bp sliding window.
Identiﬁed peaks are ranked by the false discovery rate
(FDR), which is estimated as previously describe (33).
Genuine RpoN-binding sites are peaks identiﬁed in all
three ChIP samples with a cut-off FDR value (1E-26)
that corresponds to the highest FDR for previously
known binding sites. Consensus RpoN-binding motif
was generated by searching ChIP peak regions using the
MEME Suite program (34). For RNA-Seq, gene expres-
sionlevelisrepresented asthe RPKMvalue(readsper kilo-
base per million mapped reads) (35). We use a two-fold
change in average gene expression and Student’s t-test P
value<0.05 as criteria to identify RpoN-controlled genes.
The average RPKM value for the rpoN gene was 345-fold
higher in the rpoN-positive strain than in the rpoN mutant
that had only background values, indicating a good
quality of RNA-Seq data.
Quantitative PCR (qPCR)
To validate ChIP-Seq and RNA-Seq results, qPCR was
performed using the Fast SYBR green mix (Kapa
Biosystems). For transcriptional expression analysis,
one-step qPCR was performed with the RNA-Ct one-
step system (Applied Systems). The rrsA gene, encoding
16S RNA, was used as a control sample for normalization
of difference in sample quantities.
Northern blot analysis
Total RNA (10mg) and ssRNA ladder (2mg) were mixed
with ssRNA ladder loading buffer (NEB), respectively,
and incubated at 75C for 5minutes and 4C for 2mi-
nutes. Samples were resolved on a 6% TBE-Urea gel
(Life Technologies) at 150V for 1 hour and transferred
to a Hybond N membrane at 70V for 2 hours. After
7768 Nucleic Acids Research, 2012,Vol.40, No. 16UV-cross-linking twice at 1200J, the membrane was
pre-hybridized with ULTRAhyb-Oligo buffer (Life
Technologies) at 45C for 30minutes and then hybridized
with 100pmol of
32P labeled probe overnight. The
membrane was washed twice with 2SSC (saline-sodium
citrate) buffer and exposed to ﬁlm for 24 hours before
development.
RESULTS
RpoN-recognized promoter regions identiﬁed by ChIP-Seq
As a transcription factor, the importance of RpoN in viru-
lence and other functions results from the effects of its
regulated genes. To characterize these genes and identify
RpoN-binding promoters, we performed ChIP experi-
ments in an rpoN knockout mutant expressing an
epitope-tagged RpoN or the empty vector as a control
subject. The C-terminus of RpoN was fused with a 3xV5
tag that has been shown with high ChIP efﬁciency in
V. cholerae (27). To test whether this construct is func-
tional, we examined two known RpoN-dependent traits,
motility and Hcp expression. The rpoN mutant was com-
plemented by the RpoN-3V5 construct for motility and
expression of Hcp (Figure 1), indicative of a functional
RpoN.
Using ChIP-Seq analysis, we found 68 RpoN-binding
peaks common in three replicate samples (Figure 2,
Supplementary Table S2). These peak-associated
genes are involved in motility, T6SS secretion, nitro-
gen utilization, lipoprotein and membrane and unknown
functions. By comparing all peak sequences, we
identiﬁed a consensus 15bp RpoN-binding motif,
tGG(24)cacnnttttTGC(12), capital letter indicating
highly conserved sequences (Figure 2). Although it
closely resembles the canonical RpoN-recognized
sequence identiﬁed in E. coli (15), the RpoN-binding
motif in V. cholerae differs from E. coli motif with a
more AT-rich middle region and a conserved thymine
(14). All 12 previously shown RpoN-controlled pro-
moters were conﬁrmed, including hcp and ﬂaA
(Supplementary Table S2). Forty-eight (70%) RpoN-
biding peaks were found within 250-bp upstream of an
open reading frame (ORF). There were seven RpoN-
binding sites located inside genes and distant from the 5’
end of the nearest downstream gene (Supplementary Table
S2). To validate ChIP-Seq results, we tested the ChIP en-
richment by qPCR. Results show at least 10-fold enrich-
ment for all binding sites except for VCA0925, which had
a 2.9- ± 0.6-fold enrichment (Supplementary Figure S2).
Transcriptome proﬁling of RpoN-controlled genes
by RNA-Seq
The identiﬁed RpoN-binding sites may include both silent
sites not involved in transcription and active promoters
that drive gene expression. To differentiate these, we
compared the effect of RpoN on transcriptome expression
in RpoN-expressed and RpoN-deleted conditions using
RNA-Seq analysis. The expression of 144 genes in 82
operons was positively controlled by RpoN (two-fold,
P<0.05) (Supplementary Table S3). These genes include
>50 genes for motility and chemotaxis, all genes in the
T6SS hcp1 and hcp2 operons, nitrogen utilization genes
glnB1, glnA and ntrB, genes coding for formate dehydro-
genase and phage shock proteins and >40 genes encoding
unknown functions. Of RpoN-controlled operons, 37
possess upstream ChIP-identiﬁed RpoN-binding sites
(Table 2). Thirty-ﬁve of these promoter sites are within
250bp from the 5’end of downstream genes. It is import-
ant to note that the activity of RpoN-binding promoters
requires the presence of an enhancer, and our analysis
would not detect RpoN-dependent transcripts if their
cognate enhancers were not expressed under the condi-
tions tested. A large number of genes were expressed
higher in the rpoN mutant, including many genes for me-
tabolism (Supplementary Table S4). This is likely an
indirect effect because of competition of sigma factors
for binding to the limited number of RNA core polymer-
ase (36,37). Alteration in the expression of one sigma
factor results in changes in gene expression controlled by
other sigma factors (37,38). For example, deletion of rpoN
increases the expression of genes controlled by another
sigma factor RpoS in E. coli (39).
New RpoN-dependent promoters in ﬂagellar gene clusters
Consistent with ChIP-Seq results, all genes for motility
and chemotaxis, except for ﬂrA, ﬂgA, cheV-3 and
cheR-2, showed signiﬁcant difference in expression when
RpoN was expressed (P<0.05) (Supplementary Table
S3). This is as expected because RpoN is required for
motility in V. cholerae (18). However, the RpoN-
dependence of these ﬂagellar genes varies greatly.
Flagellar genes are located in three major clusters and
are regulated by RpoN, FlrA, FlrC and FliA, which
form a four-tiered hierarchical regulation (20). Expression
of ﬂrA was independent of RpoN, whereas ﬂrC and ﬂiA
were positively controlled by RpoN. We expect genes that
require RpoN for expression to have basal expression
A
arabinose +- +-
pBAD pRpoN
RpoN
Hcp
RpoB
B WT rpoN mutant
pBAD pBAD pRpoN
Figure 1. RpoN-3V5 complements the rpoN deletion mutant. The
pBAD-derivative plasmid pRpoN carrying arabinose-inducible RpoN-
3V5 complements two known RpoN-dependent traits in the rpoN
mutant, Hcp expression (A) and motility (B).
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These include most genes in cluster 3 (ﬂgBCDEFGHIJKL,
ﬂaA and ﬂgOP), ﬂiK and motY (Figure 2). In contrast,
most genes in the other clusters exhibited little RpoN-
dependence (<4 fold) and were expressed at relatively
high levels in the rpoN mutant, suggesting the existence
of other promoters. For example, the ﬂiA gene was
expressed at considerable levels in the rpoN mutant, and
the ﬂiA gene in E. coli is known to possess both RpoD-
and FliA- recognized promoters (40). In addition, cheR-2,
a previously identiﬁed RpoN-dependent gene (20), was
expressed independent of RpoN in V52.
Using ChIP-Seq and RNA-Seq, we identiﬁed new
operon structures for ﬂagellar genes (Figure 2). In
addition to the previously characterized ﬂagellar gene
regulation (41), we found seven new RpoN-binding pro-
moters for ﬂgF, ﬂgI, ﬂhF, ﬂiD, ﬂiK, motY and ﬂgT
(Table 2). Two RpoN-binding peaks were identiﬁed
upstream of the major ﬂagellin gene VC2188 ﬂaA: one
previously known as FlrC-bound RpoN-controlled
promoter upstream of VC2189 (42) and a new RpoN
promoter located 144bp upstream of VC2188 (Table 2)
(Figure 2). Notably, previously identiﬁed RpoN-
controlled genes ﬂiLMNOPQR, ﬂhB, cheABWYZ and
2744 6470
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Figure 2. A sample of ChIP-Seq and RNA-Seq data covering the ﬂagellar region and consensus RpoN-binding motif. (A) Genomic structures are
shown above the peak panel. The height of each peak corresponds to the number of reads bound to the corresponding ChIP-site. (B) Motif was
generated based on all ChIP-peaks using MEME program. The height of each letter represents the occurrence frequency at each location.
(C) RNA-Seq data show difference in regulation of ﬂagellar genes by RpoN. The RpoN-dependence (expression ratio) is shown at the bottom
with the left axis. The absolute expression for each gene in the rpoN mutant is shown on the top with the right axis. Genes with high-RpoN-
dependence and low-expression in the rpoN mutant require RpoN for expression, whereas genes with high-expression in the rpoN mutant likely have
other promoters independent of RpoN.
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transcribed from other promoters (Supplementary
Table S3).
Identiﬁcation of a small RNA (sRNA), ﬂaX, important
for motility
RNA-Seq data revealed a highly expressed transcript that
is downstream of ﬂaA (Figure 3). We performed sequence
analysis to scan the transcript region and did not identify
any potential ORF with >20 codons, suggesting it is likely
a small RNA. To test whether it is a true transcript, we
performed northern blot analysis using sequence-speciﬁc
oligo probes. Results conﬁrmed the existence of this
sRNA (named ﬂaX), with an approximate size of 150nt.
We also used reverse-transcription PCR with primers spe-
ciﬁcally targeting ﬂaX and its adjacent 3’end of ﬂaA and
found 164.2- ± 13.6-fold higher expression for ﬂaX, con-
sistent with the RNA-Seq results. We constructed a
knock-out mutant of ﬂaX that lacks 43nt in the middle
and found that its motility was impaired in comparison
with wild type, indicating an important role of ﬂaX in
motility. In addition, the impaired motility of the ﬂaX
mutant was complemented by expressing ﬂaX in trans on
a sRNA-expression vector pNM12 (30), which has no
ribosomal-binding site upstream of the cloning site. This
sRNA is likely conserved since it was also expressed in the
V. cholerae El Tor biotype strain C6706 (data not shown).
It is also important to note that transcription of ﬂaX was
also found in the rpoN mutant, suggesting its expression is
independent of RpoN.
RpoN controls the expression of hcp but not genes on
the T6SS cluster
Data from RNA-Seq and ChIP-Seq show that none of the
T6SS genes on the main cluster was differentially
expressed on RpoN induction and there was no
RpoN-binding site. This is surprising, as previous data
examining Vibrio T6SS promoter activity in E. coli
Table 2. RpoN-regulated genes identiﬁed by RNA-Seq and ChIP-Seq
Operon Gene Function Fold change (pRpoN/pBAD) P-value ChIP-peak
T6SS
VC1415-20 hcp1/vgrG1 T6SS secretion 511.1/61.9/14.8/6.4/7.0/4.7 0.001 TGGCATCCCACTTGC
VCA0017-23 hcp2/vgrG2 T6SS secretion 532.5/94.1/19.0/14.5/12.7/2.8/3.8 0.001 TGGCATCCCACTTGC
VCA0123 vgrG3 T6SS secretion 2.4 0.001 TGGCATTGAGTTTGC
Motiliy and Chemotaxis
VC1008 motY Sodium-type ﬂagellar protein 16.9 0.001 TGGCTAGATTTTTGC
VC1384 Putative outer memberane protein 7.6 0.001 AGGTACGAAATTTGC
VC2068-66 ﬂhFG-ﬂiA Flagellar biosynthesis/sigma factor FliA 16.2/6.8/3.3 0.001 TGGAACAAATTTTGC
VC2069 ﬂhA Flagellar biosynthesis 7.4 0.001 TGGACTGAAAATTGC
VC2128 ﬂiK Flagellar hook-length control 36.2 0.001 TGGCTTACTTCTTGC
VC2134-29 ﬂiEFGHIJ Flagellar assembly 5.6/5.5/5.3/4.7/6.0/6.6 0.001 TGGCATACAAATTGC
VC2136-35 ﬂrBC Flagellar regulator 3.2/2.3 0.001 TGGCATGACTCTTGC
VC2140-38 ﬂiD/ﬂaI/ﬂiS Flagellar rod/hook-associated protein 2.1/3.4/5.2/5.4 0.001 TGGCACTAAAATTGC
VC2188 ﬂaA Flagellin core protein 251.0 0.001 TGGCACACTAATTGA
VC2189 Hypothetical protein 176.4 0.001 TGGCACGGAAGTTGC
VC2191-90 ﬂgKL Flagellar hook-associated protein 79.0/46.2 0.001 TGGCATACATATTGC
VC2193-92 ﬂgIJ Flagellar P-ring/ﬂagellar protien 67.6/47.6 0.001 TGGCACGATTTTTTA
VC2196-94 ﬂgFGH Flagellar basal rod/L-ring 183.9/84.0/93.1 0.001 TGGCATGCTGCTTGC
VC2200-2197 ﬂgBCDE Basal rod protein/hook protein E 155.2/36.9/51.0/47.3 0.001 TGGTACGCTAATTGC
VC2207-06 ﬂgOP Outer membrane proteins 79.5/23.5 0.001 GGGTATAAATTTTGC
VC2208 ﬂgT Flagellar assembly protein 2.4 0.001 TGGAACGCTCCTTGC
Regulator
VC0606-07 glnB-1 Nitrogen regulatory protein P-II 32.7/14.8 0.005 TGGCACGCCCCTTGG
VC2748 ntrB Nitrogen regulation protein 2.8 0.001 CGGCAAGATTATTGC
Enzyme and biosynthesis
VC1516-10 Formate dehydrogenase 63.9/44.6/40.7/69.4/48.1/51.6/22.3 0.001 TGGAACGCTATTTGC
VC1519 fdhD Formate dehydrogenase accessory 3.0 0.001 CGGCACCCTTTTTGC
VC1523-27 ABC transporter and molybdopterin synthesis 5.4/5.7/3.9/2.3/2.1 0.001 TGGCATCCCATTTGC
VC2746 glnA Glutamate–ammonia ligase 3.4 0.004 TGGCACGCTTTTCGC
Unknown function
VC1154 Hypothetical protein 3.8 0.001 TGGCACTCTAATTGC
VC1518-17 Hypothetical protein 7.5/10.9 0.001 TGGCGCAATTATTGC
VC1678-76 pspABC Phage shock proteins 5.9/2.5/3.2 0.001 TGGATTTATCTTTGC
VC1699 Hypothetical protein 3.8 0.012 TGGCATCGGTTTTGC
VC2005 Hypothetical protein 28.5 0.002 AGGCACAGCATTTGC
VCA0051-48 Hypothetical/GGDEF family protein 2.0/2.0/2.6/2.3 0.001 TGGCACAATTTATGC
VCA0105-06 Hypothetical protein 17.5/14.4 0.001 TGGAACATTAATTGC
VCA0144 immunogenic protein 4.9 0.012 TGGCATCTTCTTTGC
VCA0195 Hypothetical protein 4.6 0.002 CGGCGCATTTATTGC
VCA0284-86 Hypothetical protein 47.3/34.9/19.4 0.001 CGGCACCGATCATGA
VCA0734 Hypothetical protein 3.1 0.003 TGGCCTGTAATTTGC
VCA1016 Putative lipoprotein 4.3 0.010 TGGCACGCACTATGC
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co-regulated by RpoN (21). To conﬁrm our ChIP- and
RNA-Seq data, we ﬁrst compared the effect of RpoN on
the expression of hcp and the ﬁrst two genes of
T6SS cluster, vipA (VCA0107) and vipB (VCA0108)
(Figure 4). As expected, induction of RpoN increased
Hcp levels substantially (Figure 4). Surprisingly, both
VipA and VipB levels were independent of RpoN expres-
sion. In addition, the transcription levels of hcp and vgrG2
were greatly induced on RpoN induction, whereas vipA
and vipB levels were unaffected (Figure 4). We then
tested whether RpoN binds to the promoter regions of
hcp and vipAB by ChIP. There was a 90-fold enrichment
for the hcp promoter region, whereas no difference was
observed for the vipAB promoters and for the control
gene vgrG2 that is downstream of hcp, indicating that
RpoN binds to the promoter of hcp but not vipAB
in vivo. These results validate the RNA-Seq and ChIP-
Seq data and conﬁrm that the hcp operons and the
major T6SS cluster are regulated differently by RpoN.
RpoN enhancer-binding protein VasH is required
for the expression of hcp and not vipA or vipB
Because VasH is an enhancer-binding protein that acti-
vates RpoN-controlled transcription, we expect that
VasH and RpoN have similar effect on the expression of
T6SS genes. To test this, we compared the transcriptional
levels of hcp, vipA and vipB, in the wild type V52 and a
vasH deletion mutant. The expression of hcp was 1000-
fold higher in the wild type than in the vasH mutant,
whereas no signiﬁcant change in expression was
observed for vipA/B in the vasH mutant (Figure 5). This
result conﬁrms that RpoN-VasH regulates only hcp
operons but not the major cluster.
DISCUSSION
Development of next-generation sequencing technologies
provides a revolutionary tool for studying the interaction
between transcriptional factors and target DNA. In com-
parison with ChIP-chip and microarray, ChIP-Seq and
RNA-Seq analyses provide much increased sensitivity to
identify binding sites and reveal transcriptional units.
However, in comparison with the large number of
ChIP-Seq studies done in eukaryotes, much fewer have
been performed in bacteria. Here, we present the ﬁrst
example of combining ChIP and RNA-Seq data to study
the transcriptome and regulon structure controlled by an
important transcription factor RpoN. We identiﬁed 68
RpoN-binding sites and 82 RpoN-positively regulated
operons containing 144 genes. This result is comparable
with previous microarray studies in which RpoN was
found to control the expression of a large number of
genes in the classical V. cholerae strain O395 (20) and El
Tor O1 strain (19). Although the effect of RpoN on
expression of motility genes seems to be conserved, its
control on T6SS varies substantially among strains. In
El Tor O1 strain, the rpoN mutation resulted in signiﬁcant
up-regulation of the T6SS locus, whereas it had little effect
on hcp expression (19). In the classical O1 strain, the rpoN
mutation also led to increased expression of genes on the
main T6SS cluster (20). Here, we report that RpoN
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Figure 3. The new sRNA ﬂaX downstream of VC2188. (A) RNA-Seq data show a substantial increase of coverage in the downstream region of ﬂaA.
(B) Northern blot analysis conﬁrmed the existence of ﬂaX.( C) Mutation in ﬂaX attenuated motility. (D) Motility of the ﬂaX mutant was comple-
mented by expressing ﬂaX in trans on a sRNA expression vector pNM12. Arabinose (0.02%) was used for inducing the expression of ﬂaX.
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cluster. This adds to the notion that there is considerable
genomic and genetic variation in V. cholerae isolates,
especially in the context of virulence genes. For example,
the seventh pandemic El Tor O1 strain has two unique
islands, ‘Vibrio seventh pandemic island’ (VSP-I and
VSP-II), and the RTX toxin that are not present in clas-
sical strains (43). In the case of T6SS, it is constitutively
active in some Vibrio isolates (e.g. the O37-serotype V52)
but is repressed in the seventh pandemic strain under
laboratory conditions.
Of the RpoN-regulated operons, 37 operons have
upstream RpoN-binding motifs indicating direct control
by RpoN. The other operons lacking an RpoN-recognized
promoter are likely controlled through intermediate regu-
lators. For example, RpoN directly regulates the ﬂagellar
sigma factor FliA, which in turn regulates Class IV ﬂagel-
lar genes including ﬂaB and ﬂaC (41). In addition,
many genes downstream of RpoN-binding sites were not
affected by rpoN induction. This might be because of the
presence of other promoters or the inactivity of RpoN-
binding sites. The transcriptional activity of RpoN-
directed promoter depends completely on cognate
enhancer proteins, including their expression levels and
the presence of enhancer-binding sites close to the
promoter. Notably, binding of RpoN to promoter does
not require enhancer binding proteins (44). Therefore,
ChIP-Seq is able to detect RpoN-DNA interaction sites
independent of active transcription. Indeed, we found
seven binding sites that are not in close vicinity to a down-
stream gene. The physiological relevance of these binding
sites is not clear, but it is consistent with previous results
that sigma factors and RNA polymerase bind to chromo-
somal locations not involved in transcription. For
example, RNA polymerase binds to 300 inactive transcrip-
tion units (45) and a quarter of sigma 70 bound-promoters
are inactive (46). Interestingly, when using the identiﬁed
RpoN-binding motif to scan the genome, we found >300
potential RpoN-binding sites (data not shown), a number
much larger than the reported RpoN-controlled promoter
here. One predicted RpoN-binding motif is located
upstream of the major T6SS cluster VCA0107, which
was previously shown in E. coli that E. coli RpoN
controls the activity of a plasmid-borne VCA0107
B A
Figure 4. RpoN is required for the expression of Hcp but not VipA or VipB. (A) Protein levels of Hcp, VipA (VCA0107) and VipB (VCA0108) by
western blot analysis. The rpoN mutant was transformed with the plasmid pRpoN or the empty vector pBAD18. Cultures were grown aerobically in
LB medium at 37C to exponential phase (OD600=0.5), and RpoN was induced by the addition of arabinose (0.1%) for 30minutes. Samples were
taken at different time points and protein expression was detected by western blot analysis. (B) Transcriptional levels of hcp and and vipAB and
ChIP-binding of their promoter regions. The rrsA gene encoding 16S RNA was used as an internal control sample to normalize difference in total
RNA quantity among samples for qPCR. VgrG2 is located downstream of hcp2 and used as a control sample for ChIP assay. Monoclonal antibody
to RpoN-3V5 was used for ChIP assay.
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expression of hcp but not the major cluster genes vipA and vipB.
Relative gene expression was compared in wild type V52 and the
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as a control sample. RNA was extracted in exponential phase cultures
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However, this RpoN-binding motif is unlikely to be active
and transcribe VCA0107 in V. cholerae, as the predicted
transcription start site maps to the third nucleotide of the
start codon of VCA0107, which would result in an out of
frame translation. Indeed, our results of ChIP and expres-
sion analysis of RNA and protein levels show that RpoN
does not control VCA0107 expression. How RpoN select-
ively binds to some but not other similar sites is still not
clear. This selectivity may result from the effect of DNA
topology and/or exclusive binding of other global regula-
tors, such as IHF, Fis and H-NS. Nonetheless, this differ-
ence underscores the importance of experimental
veriﬁcation for in silico prediction of transcriptional
factor binding sites.
The T6SS-encoded RpoN enhancer-binding protein,
VasH, binds to the promoter of the major cluster
in vitro (21) and is required for T6SS functions (17).
However, we show that VasH, like RpoN, controls only
the expression of hcp but not vipAB. This uncoupled regu-
lation of T6SS major cluster and hcp operons by RpoN
provides a plausible explanation for the interesting results
that overexpression of vasH increases Hcp cellular levels
but not secretion in the T6SS-inactive pandemic El Tor
strain N16961 (17), as the major T6SS cluster is not
subject to RpoN regulation and thus, remains non-
induced. We postulate that regulation of the major T6SS
cluster is the key determinant for T6SS activity.
Expression of the major T6SS cluster results in not only
the expression of T6SS structural genes for Hcp secretion
but also the cognate RpoN enhancer protein VasH for
hcp expression.
The ﬂagellar gene regulatory network has been
well-characterized in previous studies (20,41). Our data
modify the previous model and identify seven new
RpoN-controlled promoters within the large clusters of
ﬂagellar genes. Some previously characterized class II ﬂa-
gellar genes controlled by RpoN likely have separate pro-
moters, as their expression does not require RpoN. We
identiﬁed an sRNA ﬂaX downstream of ﬂaA that is
required for full motility. The in silico analysis failed to
predict a clear target for ﬂaX. We are further investigating
the target using an exponential enrichment pull down
approach (47).
T6SS is under tight and complex control by regulators
LuxO, TsrA and HapR (12), and it is recently found to
be activated under high-osmolarity and low-temperature
conditions (48). Although RpoN has been known as
the critical regulator for T6SS function since T6SS was
originally discovered, our report differentiates clearly its
effect on the secreted hcp promoter and the main
T6SS promoter. Our recent model shows that the T6SS
sheath proteins VipA and VipB are in a dynamic stepwise
process of forming tubular structures, contraction, disas-
sembly and reassembly, whereas Hcp and other T6SS-
dependent molecules are secreted (49). Our ﬁndings
are consistent with this model that the regulation of secre-
tion molecules differs from the components that are
recycled.
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